Loading company…
PulseMedica develops imaging and laser treatment technologies for vitreoretinal diseases.
Founded in 2018 and based in Edmonton, Canada, PulseMedica develops imaging and treatment technologies for eye conditions including vitreous floaters, diabetic retinopathy, and age-related macular degeneration. Its products include a real-time imaging system, laser technology, and automated treatment planning tools. On July 16, 2024, it raised CAD 12 million in pre-Series A funding led by Saltagen Ventures, with Yaletown Partners and Innovation Fund among the investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in